01-LUN-57 Low-Dose Fractionated Radiation Plus Docetaxel and Cisplatin As Induction Therapy for Stage II and IIIA Non-Small Cell Lung Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date5/7/034/30/05

Funding

  • Aventis Pharmaceuticals Products Inc: $2,939.00